The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 342K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coyle, A. J.
Right arrow Articles by Gutierrez-Ramos, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coyle, A. J.
Right arrow Articles by Gutierrez-Ramos, J. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/1999/10/895/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 7, October 4, 1999 895-902

Crucial Role of the Interleukin 1 Receptor Family Member T1/ST2 in T Helper Cell Type 2–mediated Lung Mucosal Immune Responses

Anthony J. Coylea, Clare Lloyda, Jane Tiana, Trang Nguyena, Christina Erikksonb, Lin Wanga, Par Ottosonb, Per Perssonb, Tracy Delaneya, Sophie Lehara, Steve Lina, Louis Poissona, Christian Meiselc,d, Thomas Kamradtc,d, Torbjorn Bjerkeb, Douglas Levinsona, and Jose Carlos Gutierrez-Ramosa
a Department of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
b Astra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
c Deutsches Rheumaforschungs Zentrum, Berlin D-10117, Germany
d Universitätsklinikum Charite, Rheumatologie und Klinische Immunologie, D-10098 Berlin, Germany

Correspondence to: Anthony J. Coyle, Inflammation Division, Millennium Pharmaceuticals, Inc., 75 Sidney St., Cambridge, MA 02139. Tel:617-679-7347 Fax:617-551-8910 E-mail:coyle{at}mpi.com.

T1/ST2 is an orphan receptor of unknown function that is expressed on the surface of murine T helper cell type 2 (Th2), but not Th1 effector cells. In vitro blockade of T1/ST2 signaling with an immunoglobulin (Ig) fusion protein suppresses both differentiation to and activation of Th2, but not Th1 effector populations. In a nascent Th2-dominated response, anti-T1/ST2 monoclonal antibody (mAb) inhibited eosinophil infiltration, interleukin 5 secretion, and IgE production. To determine if these effects were mediated by a direct effect on Th2 cells, we next used a murine adoptive transfer model of Th1- and Th2-mediated lung mucosal immune responses. Administration of either T1/ST2 mAb or T1/ST2-Ig abrogated Th2 cytokine production in vivo and the induction of an eosinophilic inflammatory response, but failed to modify Th1-mediated inflammation. Taken together, our data demonstrate an important role of T1/ST2 in Th2-mediated inflammatory responses and suggest that T1/ST2 may prove to be a novel target for the selective suppression of Th2 immune responses.

Key Words: inflammation, eosinophil, asthma, cytokines, immunoglobulin superfamily


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS